Evidence map›Paper›PMID 34521855›Full record

ArticleNature communications2021

Parity associates with chromosomal damage in uterine leiomyomas.

Heli Kuisma, Simona Bramante, Kristiina Rajamäki, Lauri J Sipilä, Eevi Kaasinen, Jaana Kaukomaa, Kimmo Palin, Netta Mäkinen, Jari Sjöberg, Nanna Sarvilinna and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. UTERINE FIBROIDS.Physiological reviews · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Uterine Fibroid Patients Reveal Alterations in the Gut Microbiome.Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Heli Kuisma *Department of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0002-9816-3777
Simona Bramante *Department of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.
Kristiina RajamäkiDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.
Lauri J SipiläDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.
Eevi KaasinenDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0002-1333-8049
Jaana KaukomaaDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1183-4943
Kimmo PalinDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4621-6128
Netta MäkinenDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.
Jari SjöbergDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nanna SarvilinnaDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Jussi TaipaleDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0003-4204-0951
Liisa KauppiSystems Oncology Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-6759-8997
Manuela TumiatiSystems Oncology Research Program, University of Helsinki, Helsinki, Finland.
Antti HassinenFIMM-HCA, Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.ORCID 0000-0001-9491-2868
Janne PitkäniemiInstitute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry, Helsinki, Finland.
Jyrki JalkanenDepartment of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland.ORCID 0000-0001-7452-442X
Sanna HeikkinenInstitute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry, Helsinki, Finland.ORCID 0000-0001-9995-5605
Annukka PasanenDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Oskari HeikinheimoDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ralf BützowDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-4366-5099
Niko VälimäkiDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland.ORCID 0000-0001-9200-9560
Lauri A AaltonenDepartment of Medical and Clinical Genetics and Applied Tumor Genomics Research Program University of Helsinki, Helsinki, Finland. lauri.aaltonen@helsinki.fi.ORCID 0000-0001-6839-4286
University of Helsinki · FICentral Finland Health Care District · FIFinnish Cancer Registry · FIInstitute for Molecular Medicine Finland · FI

Funding

Cancer Research UK 28801
6 · The paper itself

Abstract

Mechanical forces in a constrained cellular environment were recently established as a facilitator of chromosomal damage. Whether this could contribute to tumorigenesis is not known. Uterine leiomyomas are common neoplasms that display relatively few chromosomal aberrations. We hypothesized that if mechanical forces contribute to chromosomal damage, signs of this could be seen in uterine leiomyomas from parous women. We examined the karyotypes of 1946 tumors, and found a striking overrepresentation of chromosomal damage associated with parity. We then subjected myometrial cells to physiological forces similar to those encountered during pregnancy, and found this to cause DNA breaks and a DNA repair response. While mechanical forces acting in constrained cellular environments may thus contribute to neoplastic degeneration, and genesis of uterine leiomyoma, further studies are needed to prove possible causality of the observed association. No evidence for progression to malignancy was found.

Indexed as

Chromosome AberrationsDNA RepairParityAdultBiomechanical PhenomenaDNA Breaks, Double-StrandedFemaleGene ExpressionHumansHysterectomyKaryotypeLeiomyomaMediator ComplexMutationMyocytes, Smooth MuscleMyometriumMED12 protein, humanMediator Complex

Identifiers

PMID34521855
PMCPMC8440576
OpenAlexW3200670001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.